Hyphens Pharma International (SGX:1J5) EV-to-EBITDA : 4.58 (As of May. 22, 2024)

Hyphens Pharma International EV-to-EBITDA Chart

Hyphens Pharma International Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EV-to-EBITDA	Get a 7-Day Free Trial										23.41	7.71	-	4.28	-

Competitive Comparison of Hyphens Pharma International's EV-to-EBITDA

For the Pharmaceutical Retailers subindustry, Hyphens Pharma International's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hyphens Pharma International's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Hyphens Pharma International's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Hyphens Pharma International's EV-to-EBITDA falls into.

Hyphens Pharma International EV-to-EBITDA Calculation

Hyphens Pharma International's EV-to-EBITDA for today is calculated as:

Hyphens Pharma International's current Enterprise Value is S$62.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hyphens Pharma International's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was S$13.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hyphens Pharma International  (SGX:1J5) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Hyphens Pharma International's PE Ratio for today is calculated as:

Hyphens Pharma International's share price for today is S$0.295.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hyphens Pharma International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was S$0.029.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Hyphens Pharma International EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Hyphens Pharma International's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyphens Pharma International (SGX:1J5) Business Description